Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SkyWest Inc (SKYW) vs Smith & Nephew plc (SNN) Price & Performance

SkyWest IncTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

SkyWest Inc vs Smith & Nephew plc — how do they compare? SkyWest Inc trades at $96.26 (market cap $3.73B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: Smith & Nephew plc is far larger — about 3.1× SkyWest Inc's market cap, and Smith & Nephew plc pays a 2.86% dividend while SkyWest Inc pays none. Which is the better fit depends on your goals.

SKYWSNN
Market Cap
$3.73B$11.62B
Sector
TechnologyHealth
52-Week High
$115.94$38.53
52-Week Low
$78.40$27.80
Enterprise Value
$5.51B$14.66B
Dividend Yield
2.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SkyWest Inc

SkyWest (SKYW) trades at $94.98, down 4.12% on the day, amid a bearish technical signal. The stock shows mixed earnings performance with a recent Q2 2026 miss but a Q1 beat, while maintaining solid profitability with a net margin of 9.78% and ROE of 15.34%. Valuation metrics appear attractive with a P/E of 9.44 and P/S of 0.92, below industry averages. Recent news highlights institutional interest and fleet expansion as growth drivers.

The outlook is cautiously optimistic given strong analyst support—56% buy ratings with a $112 consensus target—and robust cash flow trends. Key risks include earnings volatility, cost pressures from maintenance and fuel, and insider selling. The stock presents a value opportunity if operational execution improves, but investors should monitor quarterly results for sustained momentum.

Smith & Nephew plc

SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.

The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About SkyWest Inc

SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.

Read more on SKYW

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN